MINNEAPOLIS, May 23, 2011 /PRNewswire/ -- BioDrain Medical,
Inc. (OTC Bulletin Board: BIOR), producer of the FDA cleared
Streamway® System for automated surgical fluid disposal, announced
today the Canadian Intellectual Property Office has issued patent –
Number 2,495,747 – for the Company's Streamway System "for
disposing of liquid surgical waste for protection of healthcare
workers." The patent was granted to the Company in April of
2011.
Chad Ruwe, Chief Operating
Officer of BioDrain Medical Inc., said, "We are extremely
pleased to have been granted the Canadian patent for our Streamway
System. We now have patent protection in Europe, the United
States and Canada with
additional patents pending."
Mr. Ruwe continued, "As we place our Streamway System in
hospitals and ambulatory surgical centers, we are receiving an
enthusiastic response from medical personnel who use it daily. They
report many notable advantages, most importantly that the potential
for staff exposure to patient body fluids has been significantly
reduced, the system is easy to use and is fully automated,
providing the needed suction control and real-time fluid
measurement needed for their patients. In addition, supplies
have been greatly reduced, storage space has been freed up, and
hazardous waste costs have been lowered. We are confident the
Streamway System is setting a new standard of safety and efficiency
for disposal of liquid surgical waste."
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA
cleared, surgical fluid management system that virtually eliminates
operating room workers' exposure to blood, irrigation fluid and the
related germs, viruses and diseases that are potentially found in
the surgical environment. Today's manual surgical fluid
handling methods of hand-carrying filled surgical fluid canisters
and emptying these canisters is an exposure risk and an antiquated
approach to the handling of surgical fluid waste. BioDrain's
Streamway system fully automates the collection, measurement and
disposal of surgical fluids resulting in: 1) reducing overhead
costs to hospitals and surgical centers, 2) improving the
Occupational State and Health Association (OSHA) and other
regulatory compliance, and 3) improving the efficiency of the
operating room (and thereby making surgeries more profitable).
BioDrain's Streamway System is eco-friendly as it contributes to
cleaning up the environment. Currently, approximately 50 million
bloody, potentially disease infected, canisters go to landfills
annually in the United States.
These tainted canisters can remain in landfills for years to come.
With the installation of BioDrain's Streamway system, the
number of canisters can be significantly reduced. BioDrain
Medical, Inc. makes the operating room and our environment safer,
cleaner, and better. BioDrain products are currently being
represented by independent professional sales representatives that
cater to the needs of hospitals and ambulatory surgical centers
across the country.
Forward-looking Statements:
Certain of the matters discussed in this announcement contain
forward-looking statements that involve material risks to and
uncertainties in the company's business that may cause actual
results to differ materially from those anticipated by the
statements made herein. Such risks and uncertainties include, among
other things, our ability to establish and maintain the proprietary
nature of our technology through the patent process, as well as our
ability to possibly license from others patents and patent
applications necessary to develop products; the availability of
financing; the company's ability to implement its long range
business plan for various applications of its technology; the
company's ability to enter into agreements with any necessary
marketing and/or distribution partners; the impact of competition,
the obtaining and maintenance of any necessary regulatory
clearances applicable to applications of the company's technology;
and management of growth and other risks and uncertainties that may
be detailed from time to time in the company's reports filed with
the Securities and Exchange Commission. This is not a solicitation
to buy or sell securities and does not purport to be an analysis of
the Company's financial position. See the Company's most recent
Quarterly Report on Form 10-Q and related 8-K filings.
Investor Relations Contact:
Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: info@cfsg1.com
SOURCE BioDrain Medical, Inc.